Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXENATIDE Cause Benign prostatic hyperplasia? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Benign prostatic hyperplasia have been filed in association with EXENATIDE (Exenatide). This represents 0.1% of all adverse event reports for EXENATIDE.

23
Reports of Benign prostatic hyperplasia with EXENATIDE
0.1%
of all EXENATIDE reports
11
Deaths
18
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From EXENATIDE?

Of the 23 reports, 11 (47.8%) resulted in death, 18 (78.3%) required hospitalization, and 2 (8.7%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXENATIDE. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does EXENATIDE Cause?

Injection site haemorrhage (5,527) Device leakage (5,115) Injection site pain (4,577) Injection site mass (3,506) Blood glucose increased (3,363) Incorrect dose administered by device (3,332) Device malfunction (3,273) Wrong technique in device usage process (3,255) Device issue (2,862) Weight decreased (2,702)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which EXENATIDE Alternatives Have Lower Benign prostatic hyperplasia Risk?

EXENATIDE vs EXFORGE EXENATIDE vs EXJADE EXENATIDE vs EXTAVIA EXENATIDE vs EXTRANEAL EXENATIDE vs EYLEA

Related Pages

EXENATIDE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia EXENATIDE Demographics